Censor
- patients were censored if “Prone to death” status was determined more then 2 days after admission
Reason For Censor
| 
 | 
N
 | 
| 
Late answer
 | 
53
 | 
| 
Not Censored
 | 
9891
 | 
 
 
Table 1
Demographic and clinical features - All Patients
| 
 | 
Overall
 | 
Not prone to death
 | 
Prone to death
 | 
p
 | 
Missing
 | 
| 
n
 | 
9,891
 | 
8,918
 | 
973
 | 
 | 
 | 
| 
Age - Median (IQR)
 | 
73.2 (62.9-82.9)
 | 
72.7 (62.6-82.4)
 | 
77.7 (66.3-88)
 | 
<0.001
 | 
0
 | 
| 
Male - N (%)
 | 
5,213 (53)
 | 
4,754 (53)
 | 
459 (47)
 | 
<0.001
 | 
0
 | 
| 
BMI - Median (IQR)
 | 
26 (23.1-29.7)
 | 
26.1 (23.3-29.9)
 | 
24.2 (21-27.3)
 | 
<0.001
 | 
45.9
 | 
| 
DM - N (%)
 | 
2,818 (28)
 | 
2,584 (29)
 | 
234 (24)
 | 
0.001
 | 
0
 | 
| 
Dyslipidemia - N (%)
 | 
1,788 (18)
 | 
1,671 (19)
 | 
117 (12)
 | 
<0.001
 | 
0
 | 
| 
IHD - N (%)
 | 
2,357 (24)
 | 
2,158 (24)
 | 
199 (20)
 | 
0.01
 | 
0
 | 
| 
CHF - N (%)
 | 
1,160 (12)
 | 
1,059 (12)
 | 
101 (10)
 | 
0.186
 | 
0
 | 
| 
Stroke - N (%)
 | 
2,138 (22)
 | 
1,902 (21)
 | 
236 (24)
 | 
0.039
 | 
0
 | 
| 
Dementia - N (%)
 | 
551 (6)
 | 
424 (5)
 | 
127 (13)
 | 
<0.001
 | 
0
 | 
| 
COPD - N (%)
 | 
822 (8)
 | 
750 (8)
 | 
72 (7.4)
 | 
0.306
 | 
0
 | 
| 
Solid Malignancy - N (%)
 | 
1,680 (17)
 | 
1,185 (13)
 | 
495 (51)
 | 
<0.001
 | 
0
 | 
| 
Hematologic Malignancy - N (%)
 | 
335 (3)
 | 
307 (3)
 | 
28 (2.9)
 | 
0.406
 | 
0
 | 
| 
Chronic Meds AntiHypertensive - N (%)
 | 
5,175 (52)
 | 
4,794 (54)
 | 
381 (39)
 | 
<0.001
 | 
0
 | 
| 
Chronic Meds Antiagregants - N (%)
 | 
4,271 (43)
 | 
3,982 (45)
 | 
289 (30)
 | 
<0.001
 | 
0
 | 
| 
Chronic Meds Antiepileptic - N (%)
 | 
1,191 (12)
 | 
1,032 (12)
 | 
159 (16)
 | 
<0.001
 | 
0
 | 
| 
Chronic Meds LipidLowering - N (%)
 | 
4,421 (45)
 | 
4,191 (47)
 | 
230 (24)
 | 
<0.001
 | 
0
 | 
| 
Chronic Meds Diuretics - N (%)
 | 
2,451 (25)
 | 
2,221 (25)
 | 
230 (24)
 | 
0.407
 | 
0
 | 
| 
Chronic Meds antiCoagulant - N (%)
 | 
750 (8)
 | 
640 (7)
 | 
110 (11)
 | 
<0.001
 | 
0
 | 
| 
HGB - Median (IQR)
 | 
11.93 (10.38-13.29)
 | 
12.03 (10.55-13.38)
 | 
10.55 (9.15-12.1)
 | 
<0.001
 | 
5.7
 | 
| 
eGFR MDRD - Median (IQR)
 | 
76.5 (51.7-101.6)
 | 
77 (52.8-101.3)
 | 
71.1 (40.6-106.8)
 | 
0.005
 | 
3.9
 | 
 
Kaplan-Meier

 
Univariate analysis
Variables in univariate model
| 
 | 
exp(coef) [confint]
 | 
p
 | 
| 
prone.to.death
 | 
7.58 [7.02, 8.19]
 | 
<0.001
 | 
| 
Age
 | 
1.04 [1.04, 1.05]
 | 
<0.001
 | 
| 
Male
 | 
0.99 [0.93, 1.05]
 | 
0.796
 | 
| 
BMI
 | 
0.96 [0.95, 0.97]
 | 
<0.001
 | 
| 
DM
 | 
1.26 [1.18, 1.35]
 | 
<0.001
 | 
| 
Dyslipidemia
 | 
0.93 [0.86, 1.01]
 | 
0.069
 | 
| 
IHD
 | 
1.34 [1.26, 1.44]
 | 
<0.001
 | 
| 
COPD
 | 
1.60 [1.46, 1.76]
 | 
<0.001
 | 
| 
SolidMalignancy
 | 
2.51 [2.34, 2.69]
 | 
<0.001
 | 
| 
Dementia
 | 
2.77 [2.51, 3.06]
 | 
<0.001
 | 
| 
HematologicMalignancy
 | 
1.35 [1.16, 1.56]
 | 
<0.001
 | 
| 
ChronicMeds_AntiHypertensive
 | 
1.04 [0.98, 1.11]
 | 
0.195
 | 
| 
ChronicMeds_Antiagregants
 | 
0.95 [0.90, 1.01]
 | 
0.133
 | 
| 
ChronicMeds_Antiepileptic
 | 
1.27 [1.16, 1.38]
 | 
<0.001
 | 
| 
ChronicMeds_LipidLowering
 | 
0.74 [0.69, 0.78]
 | 
<0.001
 | 
| 
ChronicMeds_Diuretics
 | 
1.87 [1.76, 2.00]
 | 
<0.001
 | 
| 
ChronicMeds_antiCoagulant
 | 
1.64 [1.48, 1.81]
 | 
<0.001
 | 
| 
HGB
 | 
0.80 [0.79, 0.81]
 | 
<0.001
 | 
| 
eGFR_MDRD
 | 
0.99 [0.99, 0.99]
 | 
<0.001
 | 
 
Multivariate Model
Multivariate Model
| 
 | 
exp(coef) [confint]
 | 
p
 | 
| 
prone.to.death
 | 
3.25 [2.85, 3.71]
 | 
<0.001
 | 
| 
Age
 | 
1.03 [1.02, 1.03]
 | 
<0.001
 | 
| 
Male
 | 
1.17 [1.08, 1.28]
 | 
<0.001
 | 
| 
BMI
 | 
0.97 [0.96, 0.98]
 | 
<0.001
 | 
| 
DM
 | 
1.10 [1.01, 1.21]
 | 
0.031
 | 
| 
Dyslipidemia
 | 
0.89 [0.80, 0.99]
 | 
0.026
 | 
| 
IHD
 | 
0.97 [0.88, 1.07]
 | 
0.506
 | 
| 
CHF
 | 
1.57 [1.41, 1.75]
 | 
<0.001
 | 
| 
Stroke
 | 
0.98 [0.89, 1.08]
 | 
0.714
 | 
| 
Dementia
 | 
1.47 [1.26, 1.71]
 | 
<0.001
 | 
| 
COPD
 | 
1.41 [1.24, 1.60]
 | 
<0.001
 | 
| 
SolidMalignancy
 | 
1.78 [1.62, 1.96]
 | 
<0.001
 | 
| 
HematologicMalignancy
 | 
1.29 [1.08, 1.55]
 | 
0.006
 | 
| 
HGB
 | 
0.88 [0.87, 0.90]
 | 
<0.001
 | 
| 
as.factor(eGFR_MDRD < 30)TRUE
 | 
1.43 [1.27, 1.62]
 | 
<0.001
 | 
 
Propensity Matching
General mortality
##                exp(coef) [confint] p     
## prone.to.death 2.86 [2.38, 3.43]   <0.001
 
30 Day Mortality
## Call: survfit(formula = Surv(time = time.to.endpoint, event = death) ~ 
##     prone.to.death, data = propensity.data)
## 
##                 prone.to.death=0 
##         time       n.risk      n.event     survival      std.err lower 95% CI 
##      30.0000     340.0000      15.0000       0.9577       0.0107       0.9370 
## upper 95% CI 
##       0.9789 
## 
##                 prone.to.death=1 
##         time       n.risk      n.event     survival      std.err lower 95% CI 
##      30.0000     292.0000      63.0000       0.8225       0.0203       0.7837 
## upper 95% CI 
##       0.8633
Population was matched using 1:1 nearest neighbor technique. The following variables were used to perform the Matching: Age, Male, BMI,DM,Dyslipidemia,IHD,CHF,Stroke,Dementia,COPD,Solid Malignancy, Hematologic Malignancy,HGB and eGFR
Final matched cohort consisted of 710, 355 patients in each group
Univariate analysis
| 
 | 
exp(coef) [confint]
 | 
p
 | 
| 
prone.to.death
 | 
2.86 [2.38, 3.43]
 | 
<0.001
 | 
 
Quality of match

 
Survival in matched poopulation
